Vyne Therapeutics Inc (VYNE) — Financial Flexibility Index
Vyne Therapeutics Inc (VYNE) has a Financial Flexibility Index of -1.57x as of December 2025. Free cash flow of $-3.76 Million (operating CF $-3.76 Million minus capex $0.00) represents -2% of total liabilities ($2.40 Million). Check Vyne Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vyne Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Vyne Therapeutics Inc across 11 annual periods. See Vyne Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Vyne Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Vyne Therapeutics Inc. For the full company profile including market capitalisation, see Vyne Therapeutics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -13.83x | $-33.12 Million | $-33.12 Million | $2.40 Million | ▼ -505.4% |
| 2024 | -2.28x | $-33.85 Million | $-33.97 Million | $14.82 Million | ▲ +19.3% |
| 2023 | -2.83x | $-25.34 Million | $-25.34 Million | $8.95 Million | ▲ +7.3% |
| 2022 | -3.06x | $-29.20 Million | $-29.20 Million | $9.56 Million | ▲ +0.2% |
| 2021 | -3.06x | $-56.37 Million | $-56.37 Million | $18.41 Million | ▼ -25.7% |
| 2020 | -2.44x | $-136.97 Million | $-137.08 Million | $56.25 Million | ▲ +60.1% |
| 2019 | -6.11x | $-65.09 Million | $-65.10 Million | $10.66 Million | ▼ -10.9% |
| 2018 | -5.51x | $-52.59 Million | $-52.73 Million | $9.55 Million | ▼ -2317.7% |
| 2017 | -0.23x | $-28.22 Million | $-28.25 Million | $123.90 Million | ▼ -620.5% |
| 2016 | -0.03x | $-2.26 Million | $-2.29 Million | $71.49 Million | ▲ +54.8% |
| 2015 | -0.07x | $-4.18 Million | $-4.18 Million | $59.84 Million | — |